Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
DE000A2GS5D8
Tue, 27.08.2024
Dermapharm Holding SE
Dermapharm Holding SE: High-margin existing business in
branded pharmaceuticals segment drives organic growth at
German and international companies
Impressive organic growth in existing branded pharmaceuticals business at German and international companies compensates for drop in revenue due to scheduled end of pandemic-related boom in vaccine [ … ]
Thu, 27.06.2024
Dermapharm Holding SE
Dermapharm Holding SE: Annual General Meeting resolves dividend distribution of EUR 0.88 per share
2024 outlook confirmed
Board of Management and Supervisory Board actions ratified with large majority
Shareholders resolve dividend payment of EUR 0.88 per share
Distribution ratio: approximately 78% of consolidated net profit
Grünwald, 27 J [ … ]
Wed, 15.05.2024
Dermapharm Holding SE
Strong organic growth in core marketsunderscores resilience
of Dermapharm Holding SE's corporate strategy
Robust, double-digit organic growth in high-margin "branded pharmaceuticals" largely offsets projected decline in vaccine production.
Revenue in "Other healthcare products" segment down year on year due to temporary consumer reticence, pa [ … ]
Thu, 14.03.2024
Dermapharm Holding SE
Dermapharm Holding SE hits upper end of guidance range
for adjusted EBITDA, primarily due to steadily growing
international presence in branded business
» Consolidated revenue up 10.8% year on year to EUR 1,135.4 million
» Adjusted consolidated EBITDA declines by 13.8% to EUR 310.2 million
» Adjusted consolidated EBITDA margin: 27.3%
» Bo [ … ]
Wed, 15.11.2023
Dermapharm Holding SE
Dermapharm Holding SE builds on success in Q3 2023
Consolidated revenue and EBITDA (adjusted) stay on course, climbing to EUR 866.6 million and EUR 243.8 million, respectively
Expansion driven by strong organic growth in the diversified product portfolio and the acquisition of the Arkopharma Group
Adjusted consolidated EBITDA margin at 28.1 [ … ]
Tue, 29.08.2023
Dermapharm Holding SE
Dermapharm Holding SE publishes H1 2023 financial report, confirms outlook for 2023 overall
Consolidated revenue and EBITDA (adjusted) stay on course, climbing year on year to EUR 582.1 million and EUR 168.0 million, respectively
Expansion driven by Arkopharma Group and strong organic growth in branded pharmaceuticals and other healthcare p [ … ]
Wed, 16.08.2023
Dermapharm Holding SE
Dermapharm Holding SE: First half of 2023 is a success despite the challenging market environment
Consolidated revenue and EBITDA (adjusted) continue to grow as planned to EUR 582 million and EUR 168 million, respectively, compared to the corresponding period of the previous year
Growth driven by Arkopharma Group and strong organic growth o [ … ]
Wed, 14.06.2023
Dermapharm Holding SE
Dermapharm Holding SE: Annual General Meeting resolves dividend distribution of EUR 1.05 per share
2023 outlook confirmed
Board of Management and Supervisory Board actions ratified with large majority
Shareholders resolve dividend payment of EUR 1.05 per share
Distribution ratio: approximately 42% of consolidated net profit
Grünwald, 1 [ … ]
Wed, 14.06.2023
Dermapharm Holding SE
Dermapharm Holding SE: Annual General Meeting resolves dividend distribution of EUR 1.05 per share
2023 outlook confirmed
Board of Management and Supervisory Board actions ratified with large majority
Shareholders resolve dividend payment of EUR 1.05 per share
Distribution ratio: approximately 42% of consolidated net profit
Grünwald, 1 [ … ]
Tue, 13.06.2023
Dermapharm Holding SE
Dermapharm Holding SE invests in family-owned Austrian pharmaceutical company Montavit
Grünwald, 13 June 2023 – Dermapharm Holding SE ("Dermapharm"), a rapidly growing manufacturer of branded pharmaceuticals, contractually acquired a significant interest in Pharmazeutische Fabrik Montavit Gesellschaft m.b.H. ("Montavit"), Absam, Tyrol, Aust [ … ]